Universal Health Services Inc. (UHS) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
As of 2026-11-02, Universal Health Services Inc. (NYSE: UHS) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $176.05 (-0.32% 1D, market cap $10.41B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 18/20. Across 1016 tracked Health Care issuers, UHS ranks #145 in composite RQD confidence.
Within the Health Care sector (Hospital/Nursing Management), UHS carries a Roarable C (63/100 RQD), trailing P/E of 7.0x, gross margin of —, and ROIC of 14.1%. By comparison, ENSG (The Ensign Group Inc.) holds a B grade (72/100 RQD, P/E 31.6x, ROIC 18.0%, cap $10.87B) and EHC (Encompass Health Corporation) posts a B+ grade (77/100 RQD, P/E 22.9x, ROIC 13.8%, cap $12.97B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while THC leads on capital efficiency (27.6% ROIC).
Per UHS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000352915), Universal Health Services Inc. generated $17.36B in revenue (+9.7% YoY), $1.49B in net income, and $849.2M in free cash flow against $15.53B in total assets and $4.00B in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC Form 4 / 13F Thermometer: 86% Net Buy • Cannibal Buyback (-2.92% YoY Shares)
Altman Z-Score 3.11 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9
Macro rate sensitivity & RSI-14 (46.5) create a -10 pt regime headwind
Even with a 63/100 (C) score, UHS faces multiple-compression risk if 7.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Dilution & Margin Drag: Cannibal Buyback (-2.92% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($177.27) or 200D SMA ($176.73) invalidates the momentum regime and cuts Target Base ($180.01) toward Bear Floor ($140.41).
Universal Health Services Inc. (UHS) slipped -0.32% to $176.05, trading at 34% of its 52-week range ($140.08 – $246.33). Solid steady margins (14% return on capital), mixed timing at 7x P/E—hold if owned, no rush to chase.
Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
GuruFocus report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Wells Fargo analyst Stephen Baxter maintains Universal Health Services (NYSE:UHS) with a Equal-Weight and raises the price target from $166 to $170.
Hospital management company Universal Health Services (NYSE:UHS) met Wall Street’s revenue expectations in Q3 2026, with sales up 5.3% year on year to $4.73 billion. Its non-GAAP profit of $5.22 per share was 1.3% above
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +9.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on UHS today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for UHS. Explore sector supply chains on /butterfly.
Across 1016 tracked Health Care securities in the Roarable RQD universe, Universal Health Services Inc. (UHS) ranks #145 by composite RQD confidence (63/100, grade C) and #107 by equity capitalization ($10.41B). Within this direct 5-issuer industry benchmark cohort, UHS leads on earnings valuation at 7.0x trailing P/E, while THC leads on capital efficiency and profitability with 27.6% ROIC and — gross margin. EHC currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with UHS at 63/100 (C).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| UHS
ACTIVE
Universal Health Services Inc. | C | 63/100 | 7.0x | — | 14.1% | -0.32% | $10.41B | Benchmark Subject |
| ENSG The Ensign Group Inc. | B | 72/100 | 31.6x | 20.1% | 18.0% | -2.58% | $10.87B | /ensg-vs-uhs → |
| EHC Encompass Health Corporation | B+ | 77/100 | 22.9x | — | 13.8% | +3.35% | $12.97B | /ehc-vs-uhs → |
| PACS PACS Group Inc. | B | 74/100 | 41.1x | — | 24.6% | -3.76% | $7.87B | /pacs-vs-uhs → |
| THC Tenet Healthcare Corporation | B | 74/100 | 9.2x | — | 27.6% | +0.99% | $21.79B | /thc-vs-uhs → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Universal Health Services Inc. (UHS) reported GAAP revenue of $17.36B (+9.7% vs. FY2024 revenue of $15.83B , and +21.6% cumulative change since FY2023) , GAAP net income of $1.49B, operating cash flow of $1.86B, and free cash flow of $849.2M (-24.4% YoY). On the balance sheet, UHS closed FY2025 with $15.53B in total assets against $4.00B in total debt (Altman Z-Score: 3.11, Piotroski F-Score: 9/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $17.36B | $1.49B | $1.86B | $849.2M | $15.53B | $4.00B |
| FY2024 (FY) | 2024-12-31 | $15.83B | $1.14B | $2.07B | $1.12B | $14.47B | $4.46B |
| FY2023 (FY) | 2023-12-31 | $14.28B | $717.8M | $1.27B | $625.1M | $17.14B | $4.01B |
As of 2026-11-02, Universal Health Services Inc. (NYSE: UHS) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $176.05 (-0.32% 1D, market cap $10.41B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 18/20. Across 1016 tracked Health Care issuers, UHS ranks #145 in composite RQD confidence.
Within the Health Care sector (Hospital/Nursing Management), UHS carries a Roarable C (63/100 RQD), trailing P/E of 7.0x, gross margin of —, and ROIC of 14.1%. By comparison, ENSG (The Ensign Group Inc.) holds a B grade (72/100 RQD, P/E 31.6x, ROIC 18.0%, cap $10.87B) and EHC (Encompass Health Corporation) posts a B+ grade (77/100 RQD, P/E 22.9x, ROIC 13.8%, cap $12.97B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while THC leads on capital efficiency (27.6% ROIC).
Per UHS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000352915), Universal Health Services Inc. generated $17.36B in revenue (+9.7% YoY), $1.49B in net income, and $849.2M in free cash flow against $15.53B in total assets and $4.00B in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
UHS last traded at $176.05 (-0.32% on volume of 582,236 shares), positioning the stock -0.69% below its 50-day simple moving average ($177.27) and -0.38% below its 200-day simple moving average ($176.73). Across its 52-week range of $140.08 to $246.33, UHS sits at the 33.9% percentile with a 14-day RSI of 46.5 (NEUTRAL RANGE) and an implied next-earnings move of ±6.8% ($164.08 to $188.02).
Why UHS Stock slipped -0.32% Today — RQD Quant Desk Flash. Solid steady margins (14% return on capital), mixed timing at 7x P/E—hold if owned, no rush to chase.
Per the Roarable RQD rating, UHS scores 63 out of 100, a letter grade of C, with the verdict "Roarable Hold — Fair / Balanced Risk-Reward." The five pillars are:
Translated for an investor: the rating describes a company with solid cash generation, a credible balance sheet, and notable insider buying signals, offset by a neutral macro fit and only moderate institutional conviction. The valuation metrics in the market data (forward P/E of 6.5, EV/EBITDA of 5) are low, which could represent upside if earnings hold, but also may reflect market concern the source data does not explain. The verdict of "Hold" reflects this balance between upside drivers and unresolved risks.
Universal Health Services Inc. (UHS) is a NYSE-listed issuer in the Health Care sector, operating in the Hospital/Nursing Management industry. The source profile identifies it as a hospital and nursing management operator. Per the SEC financials, revenue for FY 2025 was $17364.8M. Not available in source data for detailed customer segmentation or revenue model breakdown.
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $17364.8M | $1994.0M | $1488.8M | N/A | $849.2M | $137.8M | $4004.4M |
| FY 2024 | $15827.9M | $1681.8M | $1142.1M | N/A | $1123.3M | $126.0M | $4464.5M |
| FY 2023 | $14282.0M | $1175.4M | $717.8M | N/A | $625.1M | N/A | $4010.4M |
Per the SEC financials, revenue grew from $14282.0M in FY 2023 to $17364.8M in FY 2025, and net income rose from $717.8M to $1488.8M over the same span. Per the market data, operating margin is 11.5%, net margin is 8.6%, and gross margin is reported as 0%. Per the Roarable RQD rating, ROIC is 14.1%, the Altman Z-Score is 3.11, and the Piotroski F-Score is 9/9. Debt declined from $4464.5M in FY 2024 to $4004.4M in FY 2025, and the Debt/Equity ratio is 0.55 per the rating.
Per the recent news feed, the headlines include a modest fair value cut following mixed analyst views (RISK WATCH), a bearish Seeking Alpha piece titled with a claimed 134% upside (RISK WATCH), an earnings preview (MARKET WIRE), a report that UHS missed Q3 earnings estimates despite higher patient volumes (RISK WATCH), a GuruFocus report on Q3 2026 earnings with an EPS figure cut off in the source (MARKET WIRE), and a second earnings preview (MARKET WIRE). Four items are flagged RED/RISK WATCH and two are YELLOW/MARKET WIRE. The Butterfly supply-chain graph reports no supply chain and no proprietary signals. The source data does not contain the EPS figure for Q3 2026 or the full text of the articles.
Real-time company headlines, analyst actions, and sector developments for Universal Health Services Inc. (UHS) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
GuruFocus report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.
Welcome to the UHS (Universal Health Services Inc.) Roar Pit. Current RQD Composite is 63/100 (Roarable Hold — Fair / Balanced Risk-Reward) in Hospital/Nursing Management. Bulls point to capital efficiency (14.1% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Everyone in here is repeating the bull case on UHS, but look at what you are paying: 7.0x trailing P/E with tightening sector spreads. Unless Universal Health Services Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
Looking at the 5-pillar RQD breakdown on UHS, the market is fixating on short-term headline noise in Hospital/Nursing Management and ignoring the balance sheet and cash flow trajectory. At $176.61 (52-wk range $140.08 - $246.33), any beat on forward guidance forces shorts and underweight funds to chase.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).